全文获取类型
收费全文 | 137275篇 |
免费 | 9205篇 |
国内免费 | 564篇 |
专业分类
耳鼻咽喉 | 1479篇 |
儿科学 | 4118篇 |
妇产科学 | 2352篇 |
基础医学 | 18624篇 |
口腔科学 | 2545篇 |
临床医学 | 13601篇 |
内科学 | 29079篇 |
皮肤病学 | 1720篇 |
神经病学 | 13011篇 |
特种医学 | 4265篇 |
外国民族医学 | 2篇 |
外科学 | 19616篇 |
综合类 | 1749篇 |
现状与发展 | 1篇 |
一般理论 | 164篇 |
预防医学 | 11841篇 |
眼科学 | 3641篇 |
药学 | 9849篇 |
1篇 | |
中国医学 | 292篇 |
肿瘤学 | 9094篇 |
出版年
2023年 | 684篇 |
2022年 | 1177篇 |
2021年 | 2575篇 |
2020年 | 1599篇 |
2019年 | 2641篇 |
2018年 | 3067篇 |
2017年 | 2292篇 |
2016年 | 2675篇 |
2015年 | 3008篇 |
2014年 | 4337篇 |
2013年 | 6073篇 |
2012年 | 9136篇 |
2011年 | 9723篇 |
2010年 | 5341篇 |
2009年 | 4985篇 |
2008年 | 8567篇 |
2007年 | 9106篇 |
2006年 | 8609篇 |
2005年 | 8634篇 |
2004年 | 8250篇 |
2003年 | 7544篇 |
2002年 | 7275篇 |
2001年 | 1609篇 |
2000年 | 1349篇 |
1999年 | 1628篇 |
1998年 | 1630篇 |
1997年 | 1356篇 |
1996年 | 1106篇 |
1995年 | 1084篇 |
1994年 | 933篇 |
1993年 | 919篇 |
1992年 | 966篇 |
1991年 | 937篇 |
1990年 | 869篇 |
1989年 | 839篇 |
1988年 | 763篇 |
1987年 | 758篇 |
1986年 | 655篇 |
1985年 | 784篇 |
1984年 | 751篇 |
1983年 | 684篇 |
1982年 | 823篇 |
1981年 | 711篇 |
1980年 | 622篇 |
1979年 | 533篇 |
1978年 | 469篇 |
1977年 | 454篇 |
1976年 | 373篇 |
1975年 | 367篇 |
1974年 | 396篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
71.
Dr. Paul O. Gubbins Pharm.D. Dr. Donna J. Occhipinti Pharm.D. Dr. Larry H. Danziger Pharm.D. 《Pharmacotherapy》1994,14(4):463-470
Study Objective . To determine the influence of treatment on the microbiologic outcome of funguria. Design . Retrospective case series. Setting . A 300-bed tertiary care teaching hospital in a large metropolitan area. Subjects . 141 hospitalized patients, 18 years of age or older, with at least one urine culture positive (≥ 102 cfu/ml) for fungi. Interventions . Retrospective review of medical records to determine the microbiologic outcome of funguria. Main Results . Funguria developed rapidly in individuals with known predisposing factors. Urinalysis did not routinely detect the presence of fungi or pyuria. Symptoms such as fever, dysuria, and frequency were generally absent. Funguria persisted whether it was due to Candida albicans or non-albicans species. There were no statistical differences in the microbiologic outcomes of treated and untreated funguria. Conclusions . Funguria is a rapidly developing, often benign and persistent process. Minimizing predisposing risks, such as removing indwelling urinary catheters, is beneficial in its management. Pharmacologic treatment of funguria due to C. albicans or non-albicans species does not influence the microbiologic outcome. 相似文献
72.
73.
74.
Dr. Andrew G. Bostom M.D. Dr. Anne L. Hume Pharm.D. Dr. Charles B. Eaton M.D. Dr. Joseph P. Laurino Ph.D. Ms. Lisa R. Yanek B.A. Ms. Mary S. Regan B.S. Mr. William H. McQuade M.P.H. Dr. Wendy Y. Craig Ph.D. Ms. Gayle Perrone M.B.A. Dr. Paul F. Jacques Sc.D. 《Pharmacotherapy》1995,15(4):458-464
Study Objective . To determine the efficacy of high-dose ascorbate supplementation in lowering lipoprotein(a) [Lp(a)] levels in patients with premature coronary heart disease (CHD). Design . Randomized, double-blind, placebo-controlled trial. Setting . Outpatient clinic. Patients . Forty-four patients with documented premature CHD. defined as confirmed myocardial infarction and/or angiographically determined stenosis of 50% or greater in at least one major coronary artery before age 60 years. Interventions . Patients were block randomized on the basis of age, gender, and screening Lp(a) concentrations to receive ascorbate 4.5 g/day or placebo for 12 weeks. Measurements and Main Results . High-dose ascorbate was well tolerated and produced a marked elevation in mean plasma ascorbate levels (+1.2 mg/dl; p<0.001). Multiple linear regression analysis revealed no significant effect of supplementation on postintervention Lp(a) levels (p=0.39) in a model that included treatment group assignment, and baseline Lp(a) levels. Conclusions . Our findings do not support a clinically important lowering effect of high-dose ascorbate on plasma Lp(a) in patients with premature CHD. 相似文献
75.
76.
Paul R. Finley R. Jane Williams Carla Fletcher 《Journal of clinical laboratory analysis》1988,2(4):249-255
We have devised assays to detect both circulating alloantibodies to platelets (indirect assay) and platelet-association IgG and IgM (direct assay) using a flow cytometric technique. A variety of patients with immune thrombocytopenia were studied. Employment of a confocal lens in the flow cytometer increased the discrimination power of the instrument. Patients with autoimmune thrombocytopenia (idiopathic thrombocytic purpura [ITP], systemic lupus erythematosus (SLE), lymphoma, leukemia, and drug-induced thrombocytopenia showed a significant increase in platelet-associated antibody. Circulating antibodies to platelets (alloantibodies) were demonstrated in cases of platelet refractoriness and neonatal isoimmune purpura. Day-today precision of the assays ranged from 3% to 6% (coefficient of variation). No interference was shown in the presence of hemoglobin (5 g/L), triglycerides (10 g/L), or polyclonal and monoclonal immunoglobulinemia (50 g/L: IgG, IgA, IgM). The sensitivity of the direct assay was 500 attograms of IgG or IgM platelet. 相似文献
77.
Clanton C. Shipp Paul S. Berger Manya S. Deehr Bess Dawson-Hughes M.D. 《Calcified tissue international》1988,42(5):287-292
Summary Precision of dual-photon absorptiometry (DPA) measurements was determined in a lumbar spine phantom and in humans. Approximately
half of the measurements were made before and half after a153gadolinium source change. The phantom was measured with different amounts of acrylic, which simulates human soft tissue, in
order to evaluate the influence of body thickness on bone mineral density (BMD). Results of scans analyzed with two software
versions from Lunar Radiation Corp., the widely used 08B and a prototype 08C, are compared. DPA with a cold source significantly
overestimated BMD in the phantom in the presence of large amounts (more than 25 cm) of soft tissue equivalent with version
08B but not with the newer version 08C. Similiarly, in nine subjects, there was a significant decrease in spine BMD after
a source change when scans were analyzed with version 08B (mean difference 0.026 g/cm2,P=0.002) but not with 08C (0.01 g/cm2,P=0.234). No systematic effect of source change on femoral BMD measurements was observed. The SD of the mean difference of
two measurements of the nine subjects was 0.019 g/cm2 (1.6% of the mean value) for the spine with software version 08B and 0.024 g/cm2 (2.0%) with version 08C, 0.03 g/cm2 (3.3%) for the femur neck, 0.03 g/cm2 (4.0%) for the greater trochanter, and 0.04 g/cm2 (4.9%) for Ward's triangle region of the proximal femur. The spine phanton was scanned on two other commercial bone densitometers
in order to assess inter-instrument variation. Phantom measurements of L2-4 BMD made on two Lunar Radiation Corp model DP3
scanners which differed by 2% were 10 and 12% higher than those with a Norland Corp. model 2600 scanner. 相似文献
78.
79.
80.